American tegumentary leishmaniasis - a case of therapeutic challenge
An. bras. dermatol
; 89(6): 974-976, Nov-Dec/2014. graf
Article
in English
| LILACS
| ID: lil-727633
Responsible library:
BR1.1
ABSTRACT
American Tegumentary Leishmaniasis (ATL) is a chronic, non-contagious, infectious disease affecting millions of people worldwide. The timely and proper treatment is of great importance to prevent the disease from progressing to destructive and severe forms. Treatment for ATL recommended by the Brazilian Ministry of Health is similar for the whole country, regardless of the species of Leishmania. It is known that the response to treatment may vary with the strain of the parasite, the immune status of the patient and clinical form. We report the case of a healthy patient, coming from Manaus, Amazonas state, Brazil, who presented resistance to treatment with N-methyl-glutamine and liposomal amphotericin B, only being healed after using pentamidine.
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Pentamidine
/
Leishmaniasis, Cutaneous
/
Antiprotozoal Agents
Limits:
Child
/
Female
/
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2014
Document type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Mato Grosso do Sul/BR